Emgality 120 mg solution for injection
*Company:
Eli Lilly and Company (Ireland) LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 11 February 2025
File name
Emgality_PIL_EM038_Jul24_IE-MT.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 03 February 2025
File name
Emgality_PIL_EM038_Jul24_IE-MT.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 03 February 2025
File name
Emgality_SmPC_EM037_Sep23_IE-MT.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Improved presentation of SPC
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
Emgality_pen_IFU_EM033_Sep2023_IE-NI-MT.pdf
Reasons for updating
- Replace File
Updated on 14 September 2023
File name
Emgality_SmPC_EM031_Sep23_IE-MT-NI.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.5 - Nature and contents of container
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
- Correction of spelling/typing errors
- Removal of Black Inverted Triangle
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 September 2023
File name
Emgality_PIL_EM032_Sep23_IE-NI-MT.pdf
Reasons for updating
- Change to section 6 - date of revision
- Removal of Black Inverted Triangle
- Correction of spelling/typing errors
File name
Emgality_pen_IFU_EM028_Oct22_IE-NI-MT.pdf
Reasons for updating
- Replace File
Updated on 09 November 2022
File name
Emgality_PIL_EM027_Oct22_IE-NI-MT.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Improved presentation of PIL
- Change to date of revision
Updated on 22 July 2022
File name
Emgality_SmPC_EM022_Jul22_IE-MT-NI.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 22 July 2022
File name
Emgality_PIL_EM021_Jul22_IE-NI-MT.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
File name
Emgality_pen_IFU_IE-NI-MT_Jul21.pdf
Reasons for updating
- Add New Doc
Updated on 03 May 2022
File name
Emgality_IE NI MT_SmPC_EM012.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 May 2022
File name
PIL_Emgality_Pen_IE-NI-MT.pdf
Reasons for updating
- New PIL for new product
Eli Lilly and Company (Ireland) Limited
 Limited.webp)
Address:
Dunderrow, Kinsale, Co. Cork, P17 NY71, IrelandMedical Information E-mail:
ukmedinfo@lilly.comTelephone:
+353 1 661 4377Website:
https://www.lilly.ie